SCHEMBL14825804

SCHEMBL14825804

CCOC(=O)c1ccc(CN2CCC(=C3c4ccccc4CCc4ccccc43)CC2)s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ HPGD P15428 3/20 0.52
▸ L3MBTL1 Q9Y468 3/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ HRH1 P35367 3/20 0.50
▸ PTAFR P25105 2/20 0.46
▸ SETD7 Q8WTS6 1/20 0.43
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ MAPT P10636 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ FNTA P49354 2/20 0.40
▸ FNTB P49356 2/20 0.40
▸ LMNA P02545 3/20 0.39
▸ CHRM2 P08172 2/20 0.39
▸ HTR2A P28223 2/20 0.39
▸ OPRK1 P41145 2/20 0.39
▸ HTR2B P41595 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14825796 0.89 SETD7 (0.52) KDM4EALDH1A1HPGDL3MBTL1TDP1
SCHEMBL14825805 0.85 PTAFR (0.49) KDM4EALDH1A1HPGDL3MBTL1TDP1
Hydrochloric Acid SCHEMBL14693497 0.79 KDM4E (0.54) KDM4EALDH1A1HPGDL3MBTL1TDP1
Hydrochloric Acid SCHEMBL3783252 0.77 KDM4E (0.53) KDM4EALDH1A1HPGDL3MBTL1TDP1
SCHEMBL3030543 0.77 KDM4E (0.57) KDM4EALDH1A1HPGDL3MBTL1TDP1
SCHEMBL8177110 0.77 HRH3 (0.55) KDM4EALDH1A1HPGDL3MBTL1TDP1
SCHEMBL14825801 0.76 HRH1 (0.49) KDM4EALDH1A1HPGDL3MBTL1TDP1
SCHEMBL14693488 0.76 KDM4E (0.71) KDM4EALDH1A1HPGDL3MBTL1TDP1
SCHEMBL14693597 0.76 HRH1 (0.58) KDM4EALDH1A1HPGDL3MBTL1TDP1
Hydrochloric Acid SCHEMBL9718734 0.75 HRH1 (0.55) KDM4EALDH1A1HPGDL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365553-B2 Heterocyclic compound and H1 receptor antagonist ASKA PHARMACEUTICAL CO., LTD. (JP) 2016-06-14 — — US disclosed
US-9365553-B2 Heterocyclic compound and H1 receptor antagonist ASKA PHARMACEUTICAL CO., LTD. (JP) 2016-06-14 — — US disclosed
US-20130085127-A1 HETEROCYCLIC COMPOUND AND H1 RECEPTOR ANTAGONIST ASKA PHARMACEUTICAL CO., LTD (JP) 2013-04-04 — — US disclosed
US-20130085127-A1 HETEROCYCLIC COMPOUND AND H1 RECEPTOR ANTAGONIST ASKA PHARMACEUTICAL CO., LTD (JP) 2013-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130085127-A1 HETEROCYCLIC COMPOUND AND H1 RECEPTOR ANTAGONIST HRH2, HRH4, HRH1 KDM4E 2670/4885ALDH1A1 2121/4885HPGD 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback